Trial Outcomes & Findings for Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women (NCT NCT02246114)

NCT ID: NCT02246114

Last Updated: 2017-01-16

Results Overview

The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

1 participants

Primary outcome timeframe

1 year

Results posted on

2017-01-16

Participant Flow

Participant milestones

Participant milestones
Measure
Arm A
no CO monitor
Arm B
CO monitor
Overall Study
STARTED
1
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm A
no CO monitor
Arm B
CO monitor
Overall Study
miscarriage
1
0

Baseline Characteristics

Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm A
n=1 Participants
no CO monitor
Arm B
CO monitor
Total
n=1 Participants
Total of all reporting groups
Age, Continuous
32 years
n=5 Participants
32 years
n=5 Participants
Gender
Female
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Gender
Male
0 Participants
n=5 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 year

Population: Only 1 subject enrolled in this study and she terminated early due to miscarriage at 9 weeks.

The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.

Outcome measures

Outcome data not reported

Adverse Events

Arm A (no CO Monitor)

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Arm B (CO Monitor)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Arm A (no CO Monitor)
n=1 participants at risk
no CO monitor
Arm B (CO Monitor)
CO monitor
General disorders
headache
100.0%
1/1 • Number of events 1
0/0

Additional Information

Richard S. Legro, M.D.

The Milton S. Hershey Medical Center

Phone: 717-531-6210

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place